Intangible Asset Valuation for Non-Profit Organization

Determined the Fair Market Value of certain invention disclosures, intellectual capital, know-how, trade secrets, and other intangible assets associated with drug discovery, diagnostics, and therapeutic drug development for a very broad range of cancers for a not-for-profit cancer research organization. The valuation was performed to provide information to the management and Board of Directors of the organization that was used to help guide the strategic decision-making regarding the commercialization of the technology.

Related Professionals

All Related Professionals